Loading
Loading
Rhythm Pharmaceuticals ceo salary
David P. Meeker, Chief Executive Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM), received $17,544,525 ($17.5M) in total compensation for FY2025, up 19.6% from the prior year. Stock awards of $8,274,785 were the largest component. Figures come from RHYTHM PHARMACEUTICALS, INC.'s DEF 14A filed 29 Apr 2026 (accession 0001628280-26-028375).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001628280-26-028375). These figures come from RHYTHM PHARMACEUTICALS, INC.'s DEF 14A filed 29 Apr 2026 (accession 0001628280-26-028375).
| Component | Amount |
|---|---|
| Salary | $807,692 |
| Stock awards | $8,274,785 |
| Option awards | $7,688,560 |
| Cash incentive | $759,488 |
| Other | $14,000 |
| Total | $17,544,525 |
FAQ
See also: RYTM ticker page